Lapiden

Indapamide, the active ingredient in Lapiden, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower high blood pressure and to reduce fluid accumulation in patients with heart, kidney or liver‑related edema.

GNH USA supplies Lapiden as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Indapamide is used as a thiazide‑like diuretic to manage conditions involving excess fluid or elevated blood pressure. Hypertension: lowers systolic and diastolic pressure, reducing cardiovascular risk. Edema associated with congestive heart failure: promotes fluid excretion, relieving swelling and breathlessness. Edema due to renal or hepatic disease: enhances urine output to decrease fluid overload in kidney or liver impairment.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Increased urination. - Nausea or abdominal discomfort. - Mild electrolyte disturbances such as hypokalemia. - Photosensitivity or skin rash.

Serious or Rare Side Effects: - Severe dehydration or marked electrolyte imbalance (e.g., hyponatremia, hypokalemia). - Acute gout attacks. - Pancreatitis. - Severe allergic reactions including Stevens‑Johnson syndrome. - Blood dyscrasias such as agranulocytosis or thrombocytopenia.

When prescribing indapamide, clinicians should consider several safety measures to minimize risks. - Monitor electrolytes: check serum potassium, sodium and magnesium regularly. - Assess renal function: evaluate creatinine clearance before initiation and during therapy. - Use cautiously in gout: diuretic may precipitate hyperuricemia. - Adjust dose in elderly: increased sensitivity to volume depletion. - Avoid in severe hepatic impairment: risk of accumulation and toxicity. - Store at ambient temperature: keep in original container, protect from moisture and light.

Indapamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Lithium: concurrent use may increase lithium levels and toxicity. - Cyclosporine: combined therapy can enhance nephrotoxic risk. - Antidiabetic agents: may potentiate hypoglycaemia, requiring dose adjustment.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood‑pressure lowering effect, monitor for hypotension. - NSAIDs: may reduce diuretic response and affect renal function. - Other diuretics: risk of excessive diuresis and electrolyte loss. - Beta‑blockers: may mask tachycardia from volume depletion.